These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 17588391

  • 21. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [Abstract] [Full Text] [Related]

  • 22. Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection.
    Archuleta S, Murphy B, Keller MJ.
    Transpl Infect Dis; 2004 Sep; 6(3):117-9. PubMed ID: 15569227
    [Abstract] [Full Text] [Related]

  • 23. Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin.
    Sterzik H, Soriano A, Mohamad AM, Martínez JA, Fernandez J, Cobos N, Morata L, Mensa J.
    Scand J Infect Dis; 2011 Oct; 43(10):765-70. PubMed ID: 21696252
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?
    Nathwani D.
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii37-44. PubMed ID: 12730141
    [Abstract] [Full Text] [Related]

  • 28. Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis.
    Patel R, Rouse MS, Piper KE, Steckelberg JM.
    Antimicrob Agents Chemother; 2001 Feb; 45(2):621-3. PubMed ID: 11158767
    [Abstract] [Full Text] [Related]

  • 29. Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens.
    de Feiter PW, Jacobs JA, Jacobs MJ, Vink C, van der Geest S.
    Scand J Infect Dis; 2005 Feb; 37(3):173-6. PubMed ID: 15849048
    [Abstract] [Full Text] [Related]

  • 30. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E, Sorensen S, Levrat F, Besnier JM, Dupon M, Guery B, Duttagupta S.
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Linezolid versus vancomycin for prosthetic joint infections: a cost analysis.
    You JH, Lee GC, So RK, Cheung KW, Hui M.
    Infection; 2007 Jun; 35(4):265-70. PubMed ID: 17646907
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Failure of linezolid treatment for enterococcal endocarditis.
    Zimmer SM, Caliendo AM, Thigpen MC, Somani J.
    Clin Infect Dis; 2003 Aug 01; 37(3):e29-30. PubMed ID: 12884185
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
    Álvarez-Lerma F, Palomar Martínez M, Olaechea Astigarraga P, Insausti Ordeñana J, López Pueyo MJ, Gracia Arnillas MP, Gimeno Costa R, Seijas Betolaza I.
    Rev Esp Quimioter; 2012 Mar 01; 25(1):65-73. PubMed ID: 22488544
    [Abstract] [Full Text] [Related]

  • 38. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J, Zick G, Klare I, Konstabel C, Weiler N, Sahly H.
    Antimicrob Agents Chemother; 2006 Dec 01; 50(12):4217-9. PubMed ID: 16982791
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.